Prostate Cancer Clinical Trial
Active/Not Recruiting
Active/Not Recruiting
Active/Not Recruiting
Active/Not Recruiting
Estimated trial completion date
IRRADIANT
The IRRADIANT trial is for men with intermediate-risk prostate cancer testing if a newer treatment using electrical pulses to target the tumor can control cancer as well as standard high-dose radiation but with fewer side effects.